Search for: "State v. Dow" Results 501 - 520 of 1,047
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Feb 2013, 5:16 am by Mark Summerfield
Research Affiliates, LLC v Commissioner of Patents [2013] FCA 71* (13 February 2013)* At the time of writing, the decision is not yet published on AustLII. [read post]
11 Feb 2013, 4:37 am by Susan Brenner
  Brief of Appellee United States of America, U.S. v. [read post]
28 Jan 2013, 11:46 am by Schachtman
Merrell Dow Pharm., 229 N.J. [read post]
13 Jan 2013, 4:20 pm by Lisa Larrimore Ouellette
The Supreme Court hears argument Wednesday in Gunn v. [read post]
28 Dec 2012, 2:43 am by Florian Mueller
The Apple-Samsung award needs to be adjusted here and there, but the CMU-Marvell award must simply be tossed or slashed in order to protect the innovation economy against patent unreasonableness.The cross-appeal of Judge Posner's Apple v. [read post]
18 Dec 2012, 6:54 am by Gilles Cuniberti
Related posts:Internet Defamation and Choice of Law in Dow Jones v Gutnick Nonrecognition of Foreign Defamation Judgments Workshop: Conflict of Laws and Laws of Conflict in Europe and Beyond – Patterns of Supranational and Transnational Juridification [read post]
26 Nov 2012, 9:12 am by Glenn Rosen
State Univ., 299 F.3d 1053, 1064 (9th Cir.2002).5 Fed.R.Evid. 702 (2010)6Barabin v. [read post]
24 Nov 2012, 12:38 pm by Schachtman
In addition, Havner requires that a plaintiff show ‘that he or she is similar to [the subjects] in the studies’ and that ‘other plausible causes of the injury or condition that could be negated [are excluded] with reasonable certainty’.40” 347 S.W.3d at 265 (quoting from Merrell Dow Pharmaceuticals, Inc. v. [read post]
16 Nov 2012, 1:50 pm by Bexis
Nov. 8, 2012), primarily concerning its fraudulent joinder holding – in accord with the “overwhelming weight of authority” in other states – that a hospital cannot be strictly liable for claimed defects in drugs and medical devices that are used in medical procedures within its walls. [read post]
13 Nov 2012, 3:18 pm by John J. Sullivan
  Plaintiffs argued that the federal issue wasn’t substantial enough to warrant removal, citing Merrell Dow Pharmas. v. [read post]